# Study of the Bioaccumulation of Tinzaparin in Renally Impaired Patients When Given at Prophylactic Doses

> **NCT02719418** · — · COMPLETED · sponsor: **Maisonneuve-Rosemont Hospital** · enrollment: 28 (actual)

## Conditions studied

- Renal Insufficiency, Chronic
- Deep Venous Thrombosis, Protection Against

## Interventions

- **DRUG:** Tinzaparin

## Key facts

- **NCT ID:** NCT02719418
- **Lead sponsor:** Maisonneuve-Rosemont Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-01
- **Primary completion:** 2016-09-30
- **Final completion:** 2018-12-12
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2018-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02719418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02719418, "Study of the Bioaccumulation of Tinzaparin in Renally Impaired Patients When Given at Prophylactic Doses". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02719418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*